Studies at AMP 2017 demonstrate unique user experiences and high performance of new assays and workflows for multiple sample types Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced new studies highlighting the outstanding analytical performance and ease of use of the GeneReader NGS System, the world’s first complete […]

CAMBRIDGE, England Global Gene Corp today announced a collaboration with The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James), Department of Radiation Oncology, to develop a better understanding of rare cancers in South Asian and Indian populations. The collaboration with the OSUCCC – James […]

LGC, the international life sciences company, today announced that it has appointed Emma Millican as Global NGS Business Unit Manager and Dr. Harold Swerdlow as Head of NGS Technology Development for their recently established Next Generation Sequencing Business Unit as part of their expanding Genomics division. These appointments further strengthen LGC’s in-house expertise to help drive […]

First-to-market reagents enable native gene overexpression for meaningful gain-of-function studies Available in multiple formats to support a wide range of applications   Cambridge, UK: Horizon Discovery (LSE: HZD) (“Horizon” or the “Company”), a global leader in gene editing and gene modulation technologies, today announced the launch of its reagent platform for CRISPR activation (CRISPRa) from its recently […]

Groundbreaking nucleic acid detection technology using nanomaterials DUESSELDORF – GNA Biosolutions GmbH, a molecular technology company based in Martinsried, Germany, today announced the launch of Pharos V8, the world’s first Laser PCR® platform. Pharos V8, an ultrafast PCR instrument for in vitro research use, will be showcased at the Medica Trade Fair (Exhibition Hall 3, Booth E93) from November 13-16. […]

ST. LOUIS — Canopy Biosciences™, LLC, a provider of technologies for gene editing and personalized medicine, announced today that it has launched CRISPR Complete Gene Editing Kits. The CRISPR Complete Kits are the most comprehensive CRISPR kits available, including everything a researcher needs to perform gene editing with the CRISPR-Cas9 system. CRISPR-Cas9 has revolutionized the field of […]

Outstanding and unmatched capabilities fuel strong growth in installed base and consumables use on highly versatile Sample to Insight automation solution Hilden, Germany, and Germantown, Maryland – QIAGEN N.V. (NASDAQ: QGEN; Frankfurt Prime Standard: QIA) today announced the 2,000th placement of QIAsymphony, the leading Sample to Insight workflow automation solution for molecular laboratories worldwide. The milestone […]

PORTLAND, OR and CAMBRIDGE, MA— MolecularMD announces that it has now become a Preferred Provider of Promega’s Microsatellite Instability (MSI) v1.2 Analysis System.  MolecularMD has completed validation of the MSI Analysis System for the analysis of multiple tumor types and is now offering the technology as part of a broader portfolio of diagnostic and clinical […]

HOUSTON — Genialis, Inc., a leading provider of cloud software for the visual exploration of next generation sequencing data, recently closed a $2.3M Seed round. The financing will accelerate the team’s expansion in the U.S. and commercialization of Genialis Platform. Redalpine Venture Capital in Zurich and First Star Venture Capital in Boston co-led the round, joined by Slovenian firm Pikas d.o.o. Several expert […]

BURLINGAME, Calif. – Vector Laboratories, a leader in the development and manufacture of labeling and detection reagents for biomedical research, introduces the TrueVIEW™ Autofluorescence Quenching Kit, offering the first effective technique for removing unwanted fluorescence in formalin-fixed paraffin embedded (FFPE) tissue samples, blood cells and structural elements such as collagen and elastin. Autofluorescence often impairs or […]